Ascendis Pharma’s flagship product, Yorvipath, has been making waves in the hypoparathyroidism treatment market since its launch in late 2024. Analysts have been particularly impressed with the drug’s ...

31 Oct 2024 (Johannesburg Stock Exchange) Shareholders of Ascendis Health Limited were informed ... determined as of the record date, October 25, 2024. The last day for trading to determine ...

Chinese firm 3SBio is developing a drug that is in trials to treat several forms of cancer, and Pfizer will have the right to exclusively sell it outside of China. Pfizer will pay $1.25 billion up ...

May 19 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab said it would license an experimental cancer treatment from China's 3SBio Inc (1530.HK), opens new tab, paying $1.25 billion upfront ...

“At the moment, there is very little risk” for originators that are “evergreening” their products — the practice of making minor adjustments to a drug in order to secure new patents.

(WSPA) – South Carolina Attorney General Alan Wilson announced Monday a new round of indictments connected to a multi-jurisdictional investigation into drug trafficking in Upstate counties.

Fox News Digital asked people from Houston, Texas to Detroit, Michigan to weigh in after President Donald Trump ordered pharmaceutical companies to lower drug costs this week. In an executive ...

Apnimed’s experimental drug could provide an easier alternative, and this pill now has results from a pivotal study the startup says support plans for an FDA submission. It could end up ...

On Sunday (May 18), the Stockton, Calif. rapper was booked by the Arkansas State Police on charges of criminal use of a weapon, possession of a controlled substance and theft by receiving. Few ...

Drug mule suspect Bella Culley was paid to pose as a company director so Chinese retailers could bypass an Amazon ban on trading in the UK, it was claimed last night. Culley, 18, is said to have ...